GR3030732T3 - Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent. - Google Patents

Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.

Info

Publication number
GR3030732T3
GR3030732T3 GR990401811T GR990401811T GR3030732T3 GR 3030732 T3 GR3030732 T3 GR 3030732T3 GR 990401811 T GR990401811 T GR 990401811T GR 990401811 T GR990401811 T GR 990401811T GR 3030732 T3 GR3030732 T3 GR 3030732T3
Authority
GR
Greece
Prior art keywords
drug
pharmaceutical compositions
active agent
surface active
compositions including
Prior art date
Application number
GR990401811T
Other languages
English (en)
Inventor
Fabio Carli
Daniela Lombardi
Pierandrea Esposito
Luca Dobetti
Luigi Boltri
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Publication of GR3030732T3 publication Critical patent/GR3030732T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
GR990401811T 1992-11-13 1999-07-09 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent. GR3030732T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922603A IT1256386B (it) 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo

Publications (1)

Publication Number Publication Date
GR3030732T3 true GR3030732T3 (en) 1999-11-30

Family

ID=11364286

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401811T GR3030732T3 (en) 1992-11-13 1999-07-09 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.

Country Status (7)

Country Link
US (1) US6107276A (el)
EP (1) EP0598337B1 (el)
AT (1) ATE178787T1 (el)
DE (1) DE69324442T2 (el)
ES (1) ES2132162T3 (el)
GR (1) GR3030732T3 (el)
IT (1) IT1256386B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
HUP9603364A2 (hu) * 1996-12-06 1998-12-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Ipriflavont tartalmazó csonthiány pótlására szolgáló gyógyászati készítmény és eljárás előállítására
CA2285983A1 (en) 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
EP1154759B1 (en) 1998-12-30 2008-08-13 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
ES2251985T3 (es) * 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
PL351948A1 (en) * 1999-06-04 2003-07-14 Alza Corp Implantable gel compositions and method of making thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
MXPA04000517A (es) * 2001-07-17 2006-03-03 Idemitsu Kosan Co Medicamentos profilacticos de ascitis para aves de corral.
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
CA2546115C (en) * 2003-11-14 2013-01-08 Ajinomoto Co., Inc. Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives
EP1750717B1 (en) * 2004-02-11 2017-07-19 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
US8580954B2 (en) 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
ES2382026T3 (es) 2007-09-27 2012-06-04 Wockhardt Limited Composiciones farmacéuticas autoemulsionantes de reína o diacereína
CN105168135A (zh) * 2010-03-12 2015-12-23 博格有限责任公司 辅酶Q10(CoQ10)的静脉内制剂及其使用方法
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
US10973763B2 (en) 2011-06-17 2021-04-13 Berg Llc Inhalable pharmaceutical compositions
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
ES2119748T3 (es) * 1990-03-23 1998-10-16 Yoshitomi Pharmaceutical Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.

Also Published As

Publication number Publication date
EP0598337A3 (en) 1995-06-14
ATE178787T1 (de) 1999-04-15
IT1256386B (it) 1995-12-04
DE69324442T2 (de) 1999-08-05
ES2132162T3 (es) 1999-08-16
DE69324442D1 (de) 1999-05-20
EP0598337A2 (en) 1994-05-25
EP0598337B1 (en) 1999-04-14
US6107276A (en) 2000-08-22
ITMI922603A1 (it) 1994-05-13
ITMI922603A0 (it) 1992-11-13

Similar Documents

Publication Publication Date Title
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
IL110744A0 (en) Sustained release hydrogel system for insoluble drugs and methods for the preparation thereof
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
CA2338605A1 (en) Pliable and moldable polymeric delivery system for bioactive agents
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
CA2004598A1 (en) Medicinal aerosol formulations
CA2259297A1 (en) Parenteral paclitaxel in a stable non-toxic formulation
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
EP0427519A3 (en) Swelling modulated polymeric drug delivery device
WO1993025191A3 (fr) Microspheres en polymere bioresorbable, exemptes de tensioactif, leur preparation et leur application comme medicament
PT80033A (en) Process for the preparation of pharmaceutical compounds containning bopindolole tyzanidine klotiphene clemastine or metisergid and hydropilic polymers
EP0392845A3 (en) Solid gel external drug delivery system
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
MY117808A (en) Cancer cell nuclease activator
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
EP0391852A3 (en) Pharmaceutical compositions
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
NO953647L (no) Veterinær-medikament med forlenget frigjöring
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
GB9815801D0 (en) Liquid polymeric compositions for controlled released bioactive substances
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone